| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.034 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |